Cargando…
Factors Affecting Surgical Treatment With Infliximab Therapy in Perianal Fistula With Crohn Disease
Autor principal: | Lee, Jong Lyul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Coloproctology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863008/ https://www.ncbi.nlm.nih.gov/pubmed/31725995 http://dx.doi.org/10.3393/ac.2019.10.11 |
Ejemplares similares
-
Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
por: Im, Jong Pil
Publicado: (2017) -
Treatment Strategy for Perianal Fistulas in Crohn Disease Patients: The Surgeon’s Point of View
por: Lee, Jong Lyul, et al.
Publicado: (2021) -
Infliximab for Crohn’s Disease Patients with Perianal Fistulas: Better Image, Better Life
por: Hong, Liwen, et al.
Publicado: (2020) -
Treatment of Perianal Crohn Disease Fistulae
por: Osterman, Mark T., et al.
Publicado: (2008) -
Evaluation of a Seton Procedure Combined With Infliximab Therapy (Early vs. Late) in Perianal Fistula With Crohn Disease
por: Jeon, Myunghoon, et al.
Publicado: (2019)